C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2006
08/17/2006	WO2006084746A1 Replication-deficient rna viruses as vaccines
08/17/2006	WO2006084720A2 Hpr kinase from gluconobacter oxydan
08/17/2006	WO2006084712A2 Novel gene rcs 27
08/17/2006	WO2006084711A2 Novel gene sts 22
08/17/2006	WO2006084710A2 Novel gene vcs 02
08/17/2006	WO2006084705A2 Novel gene sts 06
08/17/2006	WO2006084704A2 Novel gene sts 01
08/17/2006	WO2006084703A2 Novel gene sts 24
08/17/2006	WO2006084695A2 Tetracycline-controlled insertion element for systematic mutagenesis
08/17/2006	WO2006084664A1 Novel gene rcs 09
08/17/2006	WO2006084650A1 Sample lysis and coating of reaction surface
08/17/2006	WO2006084647A1 Gene vcs 01
08/17/2006	WO2006084645A1 Novel gene rcs 10
08/17/2006	WO2006084643A2 Novel gene vcs 07
08/17/2006	WO2006084466A2 Surface-located streptococcus pneumoniae polypeptides
08/17/2006	WO2006084388A1 Monomeric streptavidin muteins
08/17/2006	WO2006084352A1 Novel omega-3 fatty acid desaturase family members and uses thereof
08/17/2006	WO2006084340A1 Solid phase assay for methylation analysis
08/17/2006	WO2006084336A1 Gelatinization temperature manipulation
08/17/2006	WO2006071280B1 Immunoglobulins comprising predominantly a ga1g1cnacman5glcnac2 glycoform
08/17/2006	WO2006068975A3 Binding proteins specific for human matriptase
08/17/2006	WO2006066599A3 Mas related g protein coupled receptors as drug targets
08/17/2006	WO2006062723A3 Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases
08/17/2006	WO2006061650A3 Methods, products and uses involving platelets and/or the vasculature
08/17/2006	WO2006060561A3 Methods and applications of molecular beacon imaging for cancer cell detection
08/17/2006	WO2006059093A3 Fusion proteins
08/17/2006	WO2006053571A3 Template directed split and mix systhesis of small molecule libraries
08/17/2006	WO2006052806A3 Insectidical polypeptides and methods of use thereof
08/17/2006	WO2006046132A3 Method for modulating the evolution of a polypeptide encoded by a nucleic acid sequence
08/17/2006	WO2006046042A3 Method of selecting polypeptides
08/17/2006	WO2006040154A3 Prokaryotic two hybrid system
08/17/2006	WO2006039135A3 Irta-4 antibodies and their uses
08/17/2006	WO2006036872A3 Targeting opposite strand replication intermediates of single-stranded viruses by rnai
08/17/2006	WO2006033859A3 Compositions and methods for protein production
08/17/2006	WO2006026331A3 Fiber-modified adenoviral vectors for enhanced transduction of tumor cells
08/17/2006	WO2006023973A3 Control of gene expression in synergid cells
08/17/2006	WO2006021896A3 Transgenic mouse models of hepatitis c virus (hcv) and identification of hcv therapeutics
08/17/2006	WO2006015370A3 Site specific system for generating diversity protein sequences
08/17/2006	WO2006013106A3 Vaccine for prevention and treatment of hiv-infection
08/17/2006	WO2006010930A3 Enzymes
08/17/2006	WO2006005718A3 Novel sequence for improving expression of nucleic acid
08/17/2006	WO2005113817A9 Aptamer-nanoparticle conjugates and method of use for target analyte detection
08/17/2006	WO2005106039A8 Ibc-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer
08/17/2006	WO2005065239A8 Novel recombinant proteins with n-terminal free thiol
08/17/2006	WO2005049845A9 Oncolytic herpes simplex virus encoding a heterologous nitroreductase
08/17/2006	WO2005049814A3 Novel atypical pneumonia-causing virus
08/17/2006	WO2005046309A3 Tomatoes having reduced polygalacturonase activity caused by non-transgenic mutations in the polygalacturonase gene
08/17/2006	WO2005028636A3 Novel cbh1 homologs and variant cbh1 cellulases
08/17/2006	WO2005021713A3 Vectors expressing sars immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using
08/17/2006	WO2005007813A3 Novel phytase and gene
08/17/2006	WO2004089284A8 Targets for tumor growth inhibition
08/17/2006	WO2004067553A3 Tolerance-induced targeted antibody production
08/17/2006	WO2003104391A3 Antibacterial targets in alloiococcus otitidis
08/17/2006	WO2003088904A3 Screening and therapeutic methods for treating circadian rhythm disorders
08/17/2006	WO2003062391A3 Structural and cytoskeleton-associated proteins
08/17/2006	US20060185038 Methods and means for increasing the tolerance of plants to stress conditions
08/17/2006	US20060185037 Transgenic plants containing ligninase and cellulase which degrade lignin and cellulose to fermentable sugars
08/17/2006	US20060185036 Transgenic plants containing ligninase and cellulase which degrade lignin and cellulose to fermentable sugars
08/17/2006	US20060185035 Plant cellulose synthases
08/17/2006	US20060185033 Transforming plant haploid somatic tissue and using chromosome doubling agent to generate maize tissue with increased chromosomal number
08/17/2006	US20060185032 Cytochrome P450 reductases from poppy plants
08/17/2006	US20060185031 Soybean cultivar S040133
08/17/2006	US20060185030 Cytokinin response regulators and uses thereof
08/17/2006	US20060185028 Transgenic mice containing SOCS-5 cytokine signalling suppressor gene disruptions
08/17/2006	US20060185027 Systems and methods for identifying miRNA targets and for altering miRNA and target expression
08/17/2006	US20060185026 Atypical protein kinase c isoforms in disorders of the nervous system and cancer
08/17/2006	US20060185025 Human artificial chromosome (hac) vector
08/17/2006	US20060184461 Clustering system
08/17/2006	US20060183895 Materials and methods for the modification of plant lignin content
08/17/2006	US20060183892 DNA for encoding D-hydantoin hydrolases, DNA for encoding N-carbamyl-D-amino acid hydrolases, recombinant DNA containing the genes, cells transformed with the recombinant DNA, methods for producing proteins utilizing the transformed cells and methods for producing D-amino acids
08/17/2006	US20060183886 Ligands to enhance cellular uptake of biomolecules
08/17/2006	US20060183885 Oncogenic protein for use in identifying modulators which inhibit protein/protein interaction
08/17/2006	US20060183713 Compositions of low molecular weight heparin produced with modified heparinase III
08/17/2006	US20060183705 Immunoglobins; antibodies; immunogens; hepatitis b surface antigens
08/17/2006	US20060183703 Circular expression construct for gene therapeutic applications
08/17/2006	US20060183701 Methods and compositions for determining non-specific cytotoxicity of a transfection agent
08/17/2006	US20060183700 Cgrp binding nucleic acids
08/17/2006	US20060183695 Methods of increasing endogenous erythropoietin (EPO)
08/17/2006	US20060183688 Screening for drugs for treatment of pathologies involving deregulation of apoptosis including autoimmune diseases, neurological disorders and cancers
08/17/2006	US20060183687 Novel therapeutic molecules
08/17/2006	US20060183679 Peptides having a high cysteine content
08/17/2006	US20060183678 Nogo a binding molecules and pharmaceutical use thereof
08/17/2006	US20060183676 Treatment of mycobacterium tuberculosis with antisense oligonucleotides
08/17/2006	US20060183675 Controlling microorganisms; wound healing products, bandages, medical devices such as, e.g., catheters and further in anti-dandruff hair products
08/17/2006	US20060183672 having an increased activity over the wild-type human glycoprotein; reproduction disorders; cancer such as thyroid carcinoma
08/17/2006	US20060183664 Pharmaceutical composition for delayed hypersensitivity
08/17/2006	US20060183233 Transformant having an increased frequency of homologous recombination
08/17/2006	US20060183232 Packaging cells for recombinant adenovirus
08/17/2006	US20060183231 Multiple-compartment eukaryotic expression systems
08/17/2006	US20060183230 Plasmid comprising bovine papillomavirus type 1 E2 protein-dependent minichromosome maintenance element (MME) comprised of E2 multimeric binding sites can provide stable maintenance replication function to the mouse polyomavirus (PyV) core origin plasmids
08/17/2006	US20060183229 Regulatory constructs comprising intron 3 of prostate specific membrane antigen gene
08/17/2006	US20060183228 Viral vectors with surface or envelope components
08/17/2006	US20060183227 Method for gene transfer into the organelles of cells: direct gene transfer to mitochondria
08/17/2006	US20060183226 Methods for retrotransposing long interspersed elements (lines)
08/17/2006	US20060183225 producing antibodies by contacting chicken-derived B cells in which gene conversion occurs at an immunoglobulin locus with an amount of a histone deacetylase inhibitor effective for relaxing the chromatin structure of chromosomes
08/17/2006	US20060183212 Thermostable luciferases and methods of production
08/17/2006	US20060183209 Fusion protein for use in genration of preferential biopolymers in plants
08/17/2006	US20060183207 Derived from Pyrococcus furious; structure-specific cleavage agents and polymerases for the cleavage and modification of nucleic acids
08/17/2006	US20060183204 Reacting a nucleoside triphosphate with a periodate and amine compound and sodium borohydride, attaching label, a protein, an enzyme, a fatty acid, and a peptide, producing nucleic acid (DNA or RNA) fragments enzymatically extended with morpholino-nucleoside triphosphates; dna polymerases
08/17/2006	US20060183202 Method for detoxification of mycotoxins

1 ... 1758 1759 1760 1761 1762 1763 1764 1765 1766 1767 1768 1769 1770 1771 1772 1773 1774 1775 1776 1777 1778 ... 4023